Meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, -glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties

dc.contributor.authorTurker, Ferhat
dc.contributor.authorCelepci, Duygu Barut
dc.contributor.authorCelepci, Duygu Barut
dc.contributor.authorAktaş, Aydın
dc.contributor.authorTaslimi, Parham
dc.contributor.authorGök, Yetkin
dc.contributor.authorAygün, Muhittin
dc.contributor.authorGülçin, İlhami
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2019-04-29T08:03:30Z
dc.date.available2019-04-29T08:03:30Z
dc.date.created2018
dc.date.issued2018
dc.date.issuedyyyymmdd2018-07
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractmeta-Cyanobenzyl-substituted N-heterocyclic carbene (NHC) precursors were synthesized by the reaction of a series of N-(alkyl)benzimidazolium with 3-bromomethyl-benzonitrile. These benzimidazolium salts were characterized by using H-1 NMR, C-13 NMR, FTIR spectroscopy, and elemental analysis techniques. The molecular and crystal structures of 2f and 2g complexes were obtained by using the single-crystal X-ray diffraction method. The derivatives of these novel NHC precursors were effective inhibitors of -glycosidase (AG), the cytosolic carbonic anhydrase I and II isoforms (hCA I and II), butyrylcholinesterase (BChE), and acetylcholinesterase (AChE) with K-i values in the range of 1.01-2.12nM for AG, 189.56-402.44nM for hCA I, 112.50-277.37nM for hCA II, 95.45-352.58nM for AChE, and 132.91-571.18nM for BChE. In the last years, inhibition of the CA enzyme has been considered as a promising factor for pharmacologic intervention in a diversity of disturbances such as obesity, glaucoma, cancer, and epilepsy.
dc.identifier.doi10.1002/ardp.201800029
dc.identifier.issue7
dc.identifier.startpagee1800029
dc.identifier.urihttps://onlinelibrary.wiley.com/doi/full/10.1002/ardp.201800029
dc.identifier.urihttps://hdl.handle.net/11772/1124
dc.identifier.volume351
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofArchiv der Pharmazie
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectN-heterocyclic carbene precursors
dc.subjectGlycosidase
dc.subjectAcetylcholinesterase
dc.subjectButyrylcholinesterase
dc.subjectCarbonic anhydrase
dc.subjectEnzyme inhibition
dc.titleMeta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, -glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar

Lisans paketi

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: